Proliferative activity of primary cutaneous melanocytic tumours (original) (raw)
References
Ackerman AB (1980) Malignant melanoma: a unifying concept. Hum Pathol 11:591–595 Google Scholar
Ackerman AB, David KM (1986) A unifying concept of malignant melanoma: biologic aspects. Hum Pathol 17:438–440 Google Scholar
Ackerman AB, Mihara I (1985) Dysplasia, dysplastic melanocytes, dysplastic nevi, dysplastic nevus syndrome, and the malignant melanomas. Hum Pathol 16:87–91 Google Scholar
Almendri MJ, Huebsch D, Blundell AP, Macdonald-Bravo H, Bravo R (1987) Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins. Proc Natl Acad Sci USA 84:1575–1579 Google Scholar
Bentley-Phillips C, Marks R (1976) Cell division and metabolic activity of naevus cells. Br J Dermatopathol 94:557–563 Google Scholar
Bravo R, Frank R, Blundell PA, Macdonald-Bravo H (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature 326:515–517 Google Scholar
Breslow A (1975) Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg 182:572–575 Google Scholar
Clark WH Jr, From L, Bernardino EA, Mihm MC (1969) The histogenesis and biologic behavior of primary human malignant melanoma of the skin. Cancer Res 29:705–726 Google Scholar
Clark WH Jr, Elder DE, Guerry D, Epstein MN, Green MH, Horn MV (1984) A study of tumor progression. Hum Pathol 15:1147–1165 Google Scholar
Clemente C, Cochran AJ, Elder DE, Levene A, Mackie RM, Mihm MC Jr, Rilke F, Cascinelli N, Fitzpatrick TB, Sober AJ (1991) Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the world health organization melanoma programme. Hum Pathol 22:313–319 Google Scholar
Ellison DJ, Nathwani BN, Metter GE, Turner RR, Burke JS, Miller TP, Mann RB, Barcos M, Kjeldsberg CR, Winberg CD, Whitcomb CC (1987) Mitotic counts in follicular lymphomas. Hum Pathol 18:502–505 Google Scholar
Garcia RL, Coltrera MD, Grown AM (1989) Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol 134:733–739 Google Scholar
Giorno R (1984) A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol 2:161–166 Google Scholar
Hall PA, Levinson DA (1990) Assessment of cell proliferation in histological material. J Clin Pathol 43:184–192 Google Scholar
Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections. J Pathol 162:285–294 Google Scholar
Kaudewitz P, Braun-Falco O, Ernst M, Landthaler M, Stoltz W, Gerdes J (1989) Tumor cell growth fractions in human malignant melanomas and correlation to histopathologic tumor grading. Am J Pathol 134:1063–1068 Google Scholar
Kopf AW, Gross DF, Rogers GS, Rigel DS, Hellman LJ, Levenstein M, Welkovich B, Friedman RJ, Roses DF, Bart RS, Mintzis MM, Gumport SL (1987) Prognostic index for malignant melanoma. Cancer 59:1236–1241 Google Scholar
McGovern VJ, Mihm MC, Bailly C, Booth JC, Clark WH, Cochran AJ, Hardy EG, Hicks JD, Levene A, Lewis MG, Little JH, Milton GW (1973) The classification of malignant melanoma and its histologic reporting. Cancer 32:1446–1457 Google Scholar
McGurrin JF, Doria MI, Dawson PJ, Karrison T, Stein HO, Franklin WA (1987) Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast. Cancer 59:1744–1750 Google Scholar
Miyachi K, Fritzler MJ, Tan EM (1978) Autoantibody to a nuclear antigen in proliferating cells. J Immunol 121:2228–2234 Google Scholar
Moretti S, Massobrio R, Brogelli L, Novelli M, Giannotti B, Bernengo MG (1990) Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions. J Invest Dermatol 95:320–324 Google Scholar
Morris GF, Mathews MB (1989) Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 264:13856–13864 Google Scholar
Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM (1987) Monoclonal antibodies to a nuclear protein (PCNA/Cyclin) associated with DNA replication. Exp Cell Res 168:475–486 Google Scholar
Prelich G, Tan C, Kostura M, Mathews MB, So AG, Downey KM, Stillman B (1987) Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxilliary protein. Nature 326:517–518 Google Scholar
Quinn CM, Wright NA (1990) The clinical assessment of proliferation and growth in human tumours. J Pathol 160:93–102 Google Scholar
Schmoeckel C, Braun-Falco O (1978) Prognostic index in malignant melanoma. Arch Dermatol 114:871–873 Google Scholar
Shirakawa S, Luce JK, Tannock I, Feri E III (1970) Cell proliferation in human melanoma. J Clin Invest 49:1188–1199 Google Scholar
Smolle J, Soyer H-P, Kerl H (1989) Proliferative activity of cutaneous melanocytic tumors defined by Ki-67 monoclonal antibody. Am J Dermatopathol 11:301–307 Google Scholar
Takahashi H, Strutton GM, Parsons PG (1991) Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody. Histopathology 18:221–227 Google Scholar
Urso C, Bondi R, Balzi M, Sculba E, Mauri P, Becciolini A, Tarocchi S, Vallecchi C (1992) Cell kinetics of melanocytes in common and dysplastic nevi and in primary and metastatic cutaneous melanoma. Pathol Res Pract 188:323–329 Google Scholar
Worth AJ, Gallagher RP, Elwood JM, Yang PC, Lamb C, Spinelli JJ, Wood WS, Threlfall WJ, Hill GB (1989) Pathologic prognostic factors for cutaneous malignant melanoma. Int J Cancer 43:370–375 Google Scholar